Dr. John DeFord serves as EVP and CTO at BD. He joined BD in December 2017 with its acquisition of CR Bard, and served as SVP, R&D for BD Interventional. He was promoted to EVP & CTO in June 2018. John joined Bard as VP, Science and Technology in 2004; promoted to SVP, Science, Technology and Clinical Affairs in 2007. Previously, John was Managing Director of Early Stage Partners, a Midwest VC fund. Previously, he was President/CEO of Cook Incorporated, a private medical device manufacturer. John graduated from Purdue University (BS and MS in Electrical Engineering, PhD in Electrical/Biomedical Engineering).